Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | OT |
HCP reports patient had "severe cellulitis" after receiving PNEUMOVAX 23 "years ago". Per HCP, reaction was "localized to the deltoid area". Unknown if any treatment was provided. No other information provided. No additional AE. No PQC.; This spontaneous report was received from the Health Care professional and refers to a 60-year-old female patient. Her medical history, concurrent conditions and concomitant therapies were not provided. On an unknown date, reported as "years ago", the patient was administered Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) solution for injection, administered by unknown route as vaccination (dose, anatomical location, lot # and expiration date were not reported). On an unspecified date, after receiving the suspect vaccine, the patient had severe cellulitis localized to the deltoid area. Unknown if any treatment was provided. No other information provided. At the reporting time, the outcome of severe cellulitis was not known. The action taken with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23) was not reported, but established as not applicable. The causal relationship between the severe cellulitis and the suspect vaccine was not provided.